Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 13

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 13
---
 with applicable regulatory requirements, Good Clinical Laboratory Practices and our own internal rigorous quality standards. We also require that our suppliers and partners adhere to high standards, and we conduct audits and oversight of our supply chain.

In addition, it is our policy to comply with all applicable drug, medical device, diagnostic, clinical laboratory and research laws and regulations, including Food and Drug Administration registration, notification, and/or approval, marketing and sales, research and manufacturing requirements, such as Good Laboratory Practices, Good Manufacturing Practices and Good Clinical Practices, as applicable. We also comply with Clinical Laboratory Improvement Amendments of 1988 requirements and related regulations for clinical laboratory testing, where applicable.

<div align='center'>8</div>

CORPORATE GOVERNANCE Our Board Our continuing directors and their respective ages (as of April 15, 2025) and class designations are as follows:

| Name                      |     | Age |     | Director Designation |
| Michelle Griffin          |     |  59 |     | Class II Director    |
| Robert Hershberg, PhD, MD |     |  62 |     | Class I Director     |
| Peter Neupert             |     |  69 |     | Class II Director    |
| Katey Owen, PhD           |     |  56 |     | Class I Director     |
| Chad Robins               |     |  50 |     | Class III Director   |

Our Criteria for Board Nomination and Service Our criteria for board membership include specific measures for determining whether a director will be able to devote sufficient time and effort to the role, including consideration of the potential impact of service on other public company boards. This determination is made at the time of nomination and as appropriate during a director’s service on our board if their circumstances change, recognizing that the ability to fully engage in multiple activities will vary depending on the director and the activities. In that respect, our criteria relating to devotion of time and effort to the Company board include:

| • |     | Time and Effort: Willing to commit the time and energy necessary to satisfy the requirements of the board and board committee membership; attendance and participation in all board meetings and board committee meetings in which they are a member; willingness to rigorously prepare prior to each meeting and actively participate in the meeting as a thought partner; willingness to make himself/ herself available to management upon request to provide advice and counsel. |

In addition, our Bylaws currently address the question of what levels of service on other companies’ boards will be considered permissible for